UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current Trends in Neuroscience Clinical Research and Regulatory Landscape (P7-4.008)

Neurology, 2024-04, Vol.102 (17_supplement_1)

Lysandropoulos, Andreas

2024

Volltextzugriff (PDF)

Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study

Journal of rehabilitation medicine, 2021-02, Vol.53 (2), p.jrm00157

2021

Volltextzugriff (PDF)

Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity

Frontiers in neurology, 2020-05, Vol.11, p.388

2020

Volltextzugriff (PDF)

Experiences of patients with poststroke spasticity throughout a botulinum toxin treatment cycle: Results from a prospective ethnographic study

Frontiers in neurology, 2022-08, Vol.13, p.946500-946500

2022

Volltextzugriff (PDF)

Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient

Multiple sclerosis, 2013-10, Vol.19 (11), p.1551-1552

2013

Volltextzugriff (PDF)

The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part I Development and responsiveness

Journal of rehabilitation medicine, 2022, Vol.54, p.jrm00244-jrm00244

2022

Volltextzugriff (PDF)

Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects

Journal of neuroimmunology, 2011-04, Vol.233 (1), p.240-244

2011

Volltextzugriff (PDF)

Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity

Frontiers in neurology, 2020-12, Vol.11, p.629181

2020

Volltextzugriff (PDF)

HLA genotype as a marker of multiple sclerosis prognosis: A pilot study

Journal of the neurological sciences, 2017-04, Vol.375, p.348-354

2017

Volltextzugriff (PDF)

Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases

Clinical therapeutics, 2016-03, Vol.38 (3), p.670-675

2016

Volltextzugriff (PDF)

The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part II A first psychometric evaluation

Journal of rehabilitation medicine, 2022, Vol.54, p.jrm00243-jrm00243

2022

Volltextzugriff (PDF)

Pure left hippocampal stroke: a transient global amnesia-plus syndrome

Journal of neurology, 2012-05, Vol.259 (5), p.989-992

2012

Volltextzugriff (PDF)

Human Leukocyte Antigen Genotype as a Marker of Multiple Sclerosis Prognosis

Canadian journal of neurological sciences, 2020-03, Vol.47 (2), p.189-196

2020

Volltextzugriff (PDF)

Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies

Frontiers in neurology, 2020-09, Vol.11, p.576117-576117

2020

Volltextzugriff (PDF)

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

Lancet neurology, 2010-03, Vol.9 (3), p.264-272

2010

Volltextzugriff (PDF)

Quantifying brain volumes for Multiple Sclerosis patients follow‐up in clinical practice – comparison of 1.5 and 3 Tesla magnetic resonance imaging

Brain and behavior, 2016-02, Vol.6 (2), p.e00422-n/a

2016

Volltextzugriff (PDF)

Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients

Acta neurologica Belgica, 2017-03, Vol.117 (1), p.61-65

2017

Volltextzugriff (PDF)

Demyelination as a complication of new immunomodulatory treatments

Current opinion in neurology, 2010-06, Vol.23 (3), p.226-233

2010

Volltextzugriff (PDF)

Corrections required for Dressler and Johnson 2022

Journal of Neural Transmission, 2022-10, Vol.129 (10), p.1307-1308

2022

Volltextzugriff (PDF)

Patient Perceptions of Spasticity and Treatment Satisfaction Over the Course of a Botulinum Neurotoxin A (BoNT-A) Treatment Cycle: An Ethnographic Study of Stroke Survivors (1381)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Diagnostic pitfalls: Posterior ischemic optic neuropathy mimicking optic neuritis

Clinical neurology and neurosurgery, 2011-02, Vol.113 (2), p.162-163

2011

Volltextzugriff (PDF)

Patient Perspectives on the Impact of Adult Spasticity on Daily Life and its Management with Botulinum Toxin Type A (1639)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Patient perceptions of spasticity and treatment satisfaction over the course of a botulinum neurotoxin type A (BoNT-A) treatment cycle: An ethnographic study of stroke survivors

Toxicon (Oxford), 2021-01, Vol.190, p.S34-S34

2021

Volltextzugriff (PDF)

An International, Multicenter, Observational, Longitudinal Study to Assess the Effectiveness of AbobotulinumtoxinA Injections for Adult Lower Limb Spasticity: The AboLiSH Study (560)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Botulinum neurotoxins are used at low doses in the treatment of spasticity in clinical practice: results from a market research analysis

Toxicon (Oxford), 2018-12, Vol.156, p.S22-S22

2018

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(66)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Current Trends in Neuroscience Clinical Research and Regulatory Landscape (P7-4.008)

Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study

Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity

Experiences of patients with poststroke spasticity throughout a botulinum toxin treatment cycle: Results from a prospective ethnographic study

Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient

The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part I Development and responsiveness

Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects

Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity

HLA genotype as a marker of multiple sclerosis prognosis: A pilot study

Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases

The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part II A first psychometric evaluation

Pure left hippocampal stroke: a transient global amnesia-plus syndrome

Human Leukocyte Antigen Genotype as a Marker of Multiple Sclerosis Prognosis

Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

Quantifying brain volumes for Multiple Sclerosis patients follow‐up in clinical practice – comparison of 1.5 and 3 Tesla magnetic resonance imaging

Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients

Demyelination as a complication of new immunomodulatory treatments

Corrections required for Dressler and Johnson 2022

Patient Perceptions of Spasticity and Treatment Satisfaction Over the Course of a Botulinum Neurotoxin A (BoNT-A) Treatment Cycle: An Ethnographic Study of Stroke Survivors (1381)

Diagnostic pitfalls: Posterior ischemic optic neuropathy mimicking optic neuritis

Patient Perspectives on the Impact of Adult Spasticity on Daily Life and its Management with Botulinum Toxin Type A (1639)

Patient perceptions of spasticity and treatment satisfaction over the course of a botulinum neurotoxin type A (BoNT-A) treatment cycle: An ethnographic study of stroke survivors

An International, Multicenter, Observational, Longitudinal Study to Assess the Effectiveness of AbobotulinumtoxinA Injections for Adult Lower Limb Spasticity: The AboLiSH Study (560)

Botulinum neurotoxins are used at low doses in the treatment of spasticity in clinical practice: results from a market research analysis

Suchergebnisse filtern